Differences in diffusion of FDA antidepressant risk warnings across racial-ethnic groups
- PMID: 23412363
- PMCID: PMC3686566
- DOI: 10.1176/appi.ps.201200087
Differences in diffusion of FDA antidepressant risk warnings across racial-ethnic groups
Abstract
OBJECTIVE Numerous articles have identified that medical technologies diffuse more rapidly among non-Latino whites compared with other racial-ethnic groups. However, whether health risk warnings also diffuse differentially across racial-ethnic minority groups is uncertain. This study assessed racial-ethnic variation in children's antidepressant use before and after the 2004 black-box warning concerning risks of antidepressants for youths. METHODS Data consisted of responses for white, black, and Latino youths ages five through 17 from the 2002-2008 Medical Expenditure Panel Survey (N=44,422). The dependent variable was any antidepressant use in the prior year. Independent variables were race-ethnicity, year, psychological impairment, income, insurance status, region, and parents' education level. Logistic regression models were used to assess antidepressant use conditional on race-ethnicity, time, interaction between race-ethnicity and time, need, socioeconomic status, and Institute of Medicine-concordant estimates of disparities in predicted antidepressant use before and after the warning. RESULTS The warnings affected antidepressant use differentially for whites, blacks, and Latinos. Usage rates among whites decreased from 3.3 to 2.1 percentage points between prewarning and postwarning, whereas usage rates remained steady among Latinos and increased among blacks. Findings were significant in multiple regression analyses, in which predictions were adjusted for need. CONCLUSIONS The findings indicate that health safety information on antidepressant usage among children diffused faster among whites than nonwhites, suggesting the need to improve infrastructure for delivering important health messages to racial-ethnic minority populations.
Conflict of interest statement
The authors report no competing interests.
Similar articles
-
Assessing provider and racial/ethnic variation in response to the FDA antidepressant box warning.Health Serv Res. 2019 Feb;54 Suppl 1(Suppl 1):255-262. doi: 10.1111/1475-6773.13104. Health Serv Res. 2019. PMID: 30666633 Free PMC article.
-
A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills.Depress Anxiety. 2017 Dec;34(12):1147-1156. doi: 10.1002/da.22681. Epub 2017 Sep 29. Depress Anxiety. 2017. PMID: 28962069 Free PMC article.
-
Diagnosis of depression and use of antidepressant pharmacotherapy among adults in the United States: does a disparity persist by ethnicity/race?Clin Drug Investig. 2012 Feb 1;32(2):139-44. doi: 10.2165/11598950-000000000-00000. Clin Drug Investig. 2012. PMID: 22220929
-
Organ Donation in the United States: The Tale of the African-American Journey of Moving From the Bottom to the Top.Transplant Proc. 2016 Sep;48(7):2392-2395. doi: 10.1016/j.transproceed.2016.02.094. Transplant Proc. 2016. PMID: 27742306 Review.
-
Conditional risk for PTSD among Latinos: a systematic review of racial/ethnic differences and sociocultural explanations.Clin Psychol Rev. 2013 Feb;33(1):107-19. doi: 10.1016/j.cpr.2012.10.005. Epub 2012 Oct 22. Clin Psychol Rev. 2013. PMID: 23159328 Free PMC article. Review.
Cited by
-
Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries.J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):142-149. doi: 10.1016/j.japh.2021.08.023. Epub 2021 Aug 25. J Am Pharm Assoc (2003). 2022. PMID: 34509379 Free PMC article.
-
Food and Drug Administration Safety Communication on the Use of Transvaginal Mesh in Pelvic Organ Prolapse Repair Surgery: The Impact of Social Determinants of Health.Female Pelvic Med Reconstr Surg. 2021 Jan 1;27(1):e133-e138. doi: 10.1097/SPV.0000000000000863. Female Pelvic Med Reconstr Surg. 2021. PMID: 32453208 Free PMC article.
-
Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm.Int J Health Econ Manag. 2020 Sep;20(3):299-317. doi: 10.1007/s10754-020-09282-2. Epub 2020 Apr 30. Int J Health Econ Manag. 2020. PMID: 32350680 Free PMC article.
-
Assessing provider and racial/ethnic variation in response to the FDA antidepressant box warning.Health Serv Res. 2019 Feb;54 Suppl 1(Suppl 1):255-262. doi: 10.1111/1475-6773.13104. Health Serv Res. 2019. PMID: 30666633 Free PMC article.
-
A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills.Depress Anxiety. 2017 Dec;34(12):1147-1156. doi: 10.1002/da.22681. Epub 2017 Sep 29. Depress Anxiety. 2017. PMID: 28962069 Free PMC article.
References
-
- Cook BL, McGuire T, Miranda J. Measuring trends in mental health care disparities, 2000–2004. Psychiatric Services. 2007;58:1533–1540. - PubMed
-
- Garland AF, Lau AS, Yeh M, et al. Racial and ethnic differences in utilization of mental health services among high-risk youths. American Journal of Psychiatry. 2005;162:1336–1343. - PubMed
-
- Knudsen HK, Ducharme LJ, Roman PM. Racial and ethnic disparities in SSRI availability in substance abuse treatment. Psychiatric Services. 2007;58:55–62. - PubMed
-
- Kristofco RE, Stewart AJ, Vega W. Perspectives on disparities in depression care. Journal of Continuing Education in the Health Professions. 2007;27(suppl 1):S18–S25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
